These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15934513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
    Sehn LH, Connors JM.
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F, Gaulard P.
    Blood; 1996 Jan 01; 87(1):265-72. PubMed ID: 8547651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma.
    Hornberger JC, Best JH.
    Cancer; 2005 Apr 15; 103(8):1644-51. PubMed ID: 15756658
    [Abstract] [Full Text] [Related]

  • 7. The best treatment for diffuse large B-cell lymphoma: a German perspective.
    Schmits R, Schmitz N, Pfreundschuh M, German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Oncology (Williston Park); 2005 Apr 15; 19(4 Suppl 1):16-25. PubMed ID: 15934514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P, Cazals D, Mounier N, Verola O, Neidhart-Berard AM, Remenieras L, Deconinck E, Doyen C, Hamelsand J, Molina T, Moulonguet I, Gisselbrecht C.
    Leukemia; 1998 Feb 15; 12(2):213-9. PubMed ID: 9519784
    [Abstract] [Full Text] [Related]

  • 11. Treatment strategies for aggressive lymphomas: what works?
    Wilson WH.
    Hematology Am Soc Hematol Educ Program; 2013 Feb 15; 2013():584-90. PubMed ID: 24319235
    [Abstract] [Full Text] [Related]

  • 12. The role of mitoxantrone in non-Hodgkin's lymphoma.
    Armitage JO.
    Oncology (Williston Park); 2002 Apr 15; 16(4):490-502, 507-8; discussion 511-2, 514. PubMed ID: 12017536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO.
    N Engl J Med; 2005 Mar 24; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM.
    Ann Rheum Dis; 2006 Aug 01; 65(8):1033-7. PubMed ID: 16322082
    [Abstract] [Full Text] [Related]

  • 19. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
    André M, Mounier N, Leleu X, Sonet A, Brice P, Henry-Amar M, Tilly H, Coiffier B, Bosly A, Morel P, Haioun C, Gaulard P, Reyes F, Gisselbrecht C, Groupe D'Etude Des Lymphomes De L'Adulte.
    Blood; 2004 Feb 15; 103(4):1222-8. PubMed ID: 14576060
    [Abstract] [Full Text] [Related]

  • 20. Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
    Morel P, Gaulard P, Gisselbrecht C, Ferme C, Salles G, Tilly H, Brière J, Copin MC, Lederlin P, Hermine O, Theate I, Haioun C, Mounier N, Groupe d'Etude des Lymphomes de l'Adulte.
    Ann Oncol; 2008 Mar 15; 19(3):560-5. PubMed ID: 18096567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.